Most of the naturally occurring poly-or multifunctional piperidines are specific and potent inhibitors of glycosidases. They have many potential applications not only as molecular tools to investigate important biological processes but also as therapeutic agents such as antimetastatic, antitumor-poliferation, antiviral agents, etc.l) Such a multifunctional piperidine, siastatin B (1), was isolated as an inhibitor of neuraminidase by Umezawaet al.2) from a Streptomyces culture. It inhibits neuraminidases isolated from microorganisms and animal tissues as well as^-glucuronidase and 7V-acetyl-/?-D-glucosaminidase, and somewhat resembles structurally sialic acid (iV-acetylneuraminic acid, 2) ( Fig. 1 ). After achievement of the total synthesis of 13~5) and its analogues,6~9) some 7V-(l,2-dihydroxypropyl) derivatives of 1 have been synthesized, and inhibitors of Streptococcus sp. and Clostridium perfringens neuraminidases, have been obtained. In this paper, the syntheses and the biological activities of TV-substituted derivatives of siastrain B, 4-deoxysiastatin B and 3,4-didehydro-4-deoxysiastatin B (7~21) are presented. Synthesis In the course of our molecular graphics study8'9) of the relationship between structure and biological activity among such inhibitors, we became interested in the substitution at the imino group of the piperidine ring which we believe interacts with the glycopyranosyl binding site to inhibit the enzymatic process. Thus, compounds 7~21 were prepared from 1, its methyl ester (22), 4-deoxysiastatin B methyl ester8) (23), 3,4-didehydro-4-deoxysiastatin B8) (24) or its methyl ester8) (25), by N-benzylation or reductive 7V-alkylation. Treatment of 1, for example, with benzyl chloride and triethylamine in an aqueous N,JV-dimethylformamide (DMF) solution gave 7 in 73% yield (Scheme 1). Compounds 20 and 21 were similarly prepared from 24 Scheme 1. and 25. Reductive iV-alkylation of 23 with benzaldehyde by sodium cyanoborohydride (NaBH3CN) in methanol afforded 8 which was converted into 9 by alkaline hydrolysis in a good yield. Compounds 10~17 were also efficiently obtained from 22 and the corresponding aldehydes by the similar reaction sequences. On the other hand, compounds18 and 19 were prepared by reductive N-alkylation from 1 with 2-methylpropanal and 2,2-dimethylpropanal, respectively, in good yields.
Biological Activities As shown in Table 1 , compounds 7, 9, ll, 13, OCT. 1992 No other analogues showed inhibitory activity against glycosidases (a-glucosidase from yeast, jS-glucosidase from almond, a-mannosidase from soybean, jS-glucuronidase from bovine liver, a-amylase from porcine pancreas, /?-amylase from sweet potato, a-and /?-galactosidase from Escherichia coli, /?-galactosidase from bovine liver, iV-acetyl-a-galactosidase from chicken liver and Af-acetyl-^-glucosaminidase from bovine liver). Further evaluation of the biological activities of these analogues are in progress.
Experimental

General Methods
Melting points were derermined with a Yanagimotoapparatus and are uncorrected. IR spectra were determined on a Hitachi Model 260-10 spectrophotometer. Optical rotations were measured with a Perkin-Elmer Model 241 polarimeter. *H NMRspectra were recorded with a JEOL JNM-GX400 spectrometer. Chemical shifts are expressed in S values (ppm) with tetramethylsilane as an internal standard.
Mass spectra were taken by a JEOL JMS-SX102 in the FAB mode.
N-Benzylsiastatin B (7) To a solution of siastatin B (1, 50mg) in a mixture of DMF(3ml) and H2O (lml) were added triethylamine (0.5ml) and benzyl chloride (0.2ml), and the mixture was stirred at room temperature overnight. Evaporation of the solvent gave an oil. The oil was subjected to preparative TLCon silica gel developed with a mixture of CHC13-MeOH-cone aq ammonia (20 : 10 : 3) to give a colorless amorphous solid of7 (51.6mg, 73%): [a]^5 +3.2°(c 0.48, H2O); IR (KBr) cm"1 3400 (sh), 3150, 3050, 2825, 2600 (sh), 1730, 1690, 1550, 1410, 1290, 1230, 1170, 1140, 1110, 1040, 990, 960, 920, 885 (69 mg), and the mixture was stirred at room temperature overnight. Another portion of benzaldehyde (0.09ml) and NaBH3CN(33mg) were added to the mixture, and then the reaction mixture was further stirred at room temperature for 4 hours. Addition of water and evaporation of the solvent gave a solid, which was taken up in chloroform. Evaporation of the solvent gave a foam. The foam was subjected to preparative TLC developed with a mixture of CHC13-MeOH-cone aq ammonia (20: 10:3) iV-Benzyl-4-deoxysiastatin B (9) To a solution of 8 (45mg) in MeOH(2.3ml) was added 1 m NaOH(0.59ml), and the mixture was stirred at room temperature for 5 hours. Evaporation of the solvent gave a solid. The solid was subjected to preparative TLC on silica gel developed with a mixture ofCHC13-MeOH-cone aq ammonia (20 : 10 : 3) to give a colorless amorphous solid of 9 (43mg, 100% 1 3340, 3070, 2975, 2930, 2840, 1950, 1660, 1595, 1550, 1500, 1470, 1440, 1420, 1400, 1390, 1360, 1345, 1325, 1300, 1280, 1260, 1230, 1220, 1180, 1150, 1120, 1110, 1105, 1090, 1080, 1030, 970, 950, 920, ' 1 3400, 1640, 1610, 1580, 1560, 1500, 1470, 1410, 1315, 1290, 1270, 1250, 1235, 1220, 1200, 1175, 1150, 1120, 1100, 1070, 960, 950, 930 iV-Propylsiastatin B Methyl Ester (16) Compound16 was obtained from 22 and propanal by a similar procedure to that used for the preparation of8 (yield 643%): [oc]£9 -17°(c 0.23, MeOH); IR (KBr) cm ' 1 3500 (sh), 3430, 3300, 2975, 2880, 2850, 1750, 1740, 1725, 1710, 1660, 1560, 1440, 1380, 1340, 1320, 1300 (sh), 1290, 1275, 1225, 1210, 1185, 1170, 1130, 1110, 1060, 1010, 980, 950, 930, 920, 910 ; *H NMR (400MHz, D2O) S 0.85 (3H, t, J=7Hz, CH3), 2.09 (3H, s, NCOCH3), 1.3-1.7 (2H, m, CCH2C), 2.31 and 2.65 (each 1H, dt, 7=5 and 12Hz, NCH2), 2.72 (1H, t, /=13Hz, 2-Hax), 2.89 (1H, ddd, /=3, 4 and 13Hz, 3-H), 3.10 (1H, dd, J=4 and 13Hz, 3.49 (1H, dd, /=3 and 10Hz, 4.35 (1H, d, /=10Hz, 4.45 (1H, t, /=3Hz, Compound17 was obtained from 16 by a similar procedure to that used for the preparation of 9
(yield 82%): [a]£9 -2.9°(c 0.44, H2O); IR (KBr) cm "1 3450, 3220, 2970 , 2880 , 2730 , 1690 , 1670 , 1610 , 1550 , 1390 , 1340 , 1310 , 1270 , 1240 , 1215 , 1160 , 1140 , 1110 , 1060 , 1010 XH NMR (400MHz, D2O with a few drops ofpyridine-</5) S 0.74 (3H, t, CH3), 1.24-1.56 (2H, m, CH2), 2.01 (3H, s, NCOCH3), 2.20 and 2.55 (each 1H, ddd, /=5, ll and 13Hz, NCH2), 2.50 (1H, ddd, /=3, 4 and 12Hz, 2.63 (1H, t, 7=12Hz, 2.92 (1H, dd, J=4 and 12Hz, 3.45 (1H, dd, J=3 and 9.5Hz, 4.33 (1H, t, /=3Hz, 4.34 (1H, d, /=9.5Hz, 1 3400, 3350, 3320, 3260, 3225, 2975, 1700, 1620, 1550, 1470, 1410, 1390, 1350, 1310, 1270, 1250, 1220, 1170, 1140, 1115, 1065, 1010, 980, 
Siastatin B Methyl Ester (22)
A solution of 1 (487mg) in dry MeOH (15ml) was stirred with Amberlist 15 (H+) (500mg) at room temperature for 1 day. After addition of cone aq ammonia (pH~9), the resin was filtered off. Evaporation of the filtrate gave a solid, which was subjected to the column chromatography on silica gel. Elution with a mixture of CHC13-MeOH-coneaq ammonia (20: 10:3) gave a colorless solid of22 (434mg, 83.7%). The solid was crystallized from MeOHto give colorless crystals: MP 177~178°C; [a]J5 + 18°(c 0.59, H2O); IR (KBr) cm "1 3530, 3380, 3300, 3130, 3000, 2960, 2930, 1770, 1750, 1670, 1585, 1465, 1450, 1400, 1365, 1345, 1320, 1295, 1285, 1265, 1250, 1220, 1185, 1155, 1145, 1110, 1095, 1065, 1030, 1000, 980, 960, 930, 910; *H NMR (400MHz, D2O) <S 2.44 (3H, s, NCOCH3), 3.85 (1H, ddd, J=2, 6 and llHz, m, 3.55 (1H, dd, J=2 and lOHz, 3.75 (3H, s, COOCH3), 4.49 (1H, t, 7=2Hz, d, 7=10Hz, 
